Clinical trial
Histoblood Group Antigens as a Risk Factor of Asthma
NCT00201266 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00201266 |
|---|---|
| Title | Histoblood Group Antigens as a Risk Factor of Asthma |
| Official title | Histoblood Group Antigens, Viruses and Asthma |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Asthma, Lung Diseases |
| Intervention type | Procedure |
| Interventions | Screening |
| Enrollment | 126 |
| Start date | Jul 1, 2005 |
| Primary completion | Aug 1, 2011 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: